Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 0.8275 USD -7.75%
Market Cap: 7.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Wall Street
Price Targets

TRIB Price Targets Summary
Trinity Biotech PLC

There are no price targets for TRIB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Trinity Biotech PLC Competitors:
Price Targets
300529
Jafron Biomedical Co Ltd
43% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
10% Downside
6960
Fukuda Denshi Co Ltd
15% Downside
EW
Edwards Lifesciences Corp
6% Upside
COH
Cochlear Ltd
1% Upside
100120
Vieworks Co Ltd
39% Upside
GMED
Globus Medical Inc
17% Upside
TNDM
Tandem Diabetes Care Inc
46% Upside

Revenue
Forecast

Revenue Estimate
Trinity Biotech PLC

For the last 8 years the compound annual growth rate for Trinity Biotech PLC's revenue is -7%. The projected CAGR for the next 3 years is 12%.

-7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Trinity Biotech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Trinity Biotech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRIB's stock price target?
Not Available

TRIB doesn't have any price targets made by Wall Street professionals.

What is Trinity Biotech PLC's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Trinity Biotech PLC's revenue is -7%. The projected CAGR for the next 3 years is 12%.

Back to Top